1. Home
  2. AMRX vs FBIN Comparison

AMRX vs FBIN Comparison

Compare AMRX & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$18.03

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

HOLD

Current Price

$45.45

Market Cap

5.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
FBIN
Founded
2002
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.5B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
AMRX
FBIN
Price
$18.03
$45.45
Analyst Decision
Strong Buy
Hold
Analyst Count
5
11
Target Price
$15.60
$54.60
AVG Volume (30 Days)
1.8M
2.6M
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
2.58%
EPS Growth
157.89
N/A
EPS
0.37
0.01
Revenue
N/A
$4,463,200,000.00
Revenue This Year
$4.48
$2.68
Revenue Next Year
$7.13
$3.60
P/E Ratio
$48.62
$4,631.00
Revenue Growth
N/A
N/A
52 Week Low
$9.32
$32.34
52 Week High
$19.26
$64.84

Technical Indicators

Market Signals
Indicator
AMRX
FBIN
Relative Strength Index (RSI) 53.02 42.04
Support Level $16.61 $44.04
Resistance Level $18.13 $53.84
Average True Range (ATR) 0.58 1.44
MACD -0.06 -0.34
Stochastic Oscillator 64.32 18.71

Price Performance

Historical Comparison
AMRX
FBIN

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About FBIN Fortune Brands Innovations Inc.

Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.

Share on Social Networks: